Literature DB >> 15472126

Essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury.

Qingwei Zhao1, Kensuke Egashira, Ken-ichi Hiasa, Minako Ishibashi, Shujiro Inoue, Kisho Ohtani, Chunyan Tan, Masabumi Shibuya, Akira Takeshita, Kenji Sunagawa.   

Abstract

OBJECTIVE: Vascular endothelial growth factor (VEGF) is upregulated after arterial injury. Its role in the pathogenesis of neointimal formation after periadventitial injury, however, has not been addressed. METHODS AND
RESULTS: Expression of VEGF and its receptors but not that of placental growth factor markedly increased with the development of neointimal formation in hypercholesterolemic mice after cuff-induced periarterial injury. Transfection with the murine soluble Flt-1 (sFlt-1) gene to block VEGF in vivo in mice inhibited early inflammation and later neointimal formation. The sFlt-1 gene transfer did not affect plasma lipid levels but attenuated increased expression of VEGF, Flt-1, Flk-1, monocyte chemoattractant protein-1, and other inflammation-promoting factors. Mice with Flt-1 kinase deficiency also displayed reduced neointimal formation.
CONCLUSIONS: Inflammatory changes mediated by VEGF and Flt-1 signals play an important role in the pathogenesis of neointimal formation after cuff-induced periadventitial injury. VEGF might promote neointimal formation by acting as a proinflammatory cytokine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472126     DOI: 10.1161/01.ATV.0000147161.42956.80

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

Review 1.  Progress of molecular targeted therapies for prostate cancers.

Authors:  Weihua Fu; Elena Madan; Marla Yee; Hongtao Zhang
Journal:  Biochim Biophys Acta       Date:  2011-11-29

2.  VEGF blockade inhibits lymphocyte recruitment and ameliorates immune-mediated vascular remodeling.

Authors:  Jiasheng Zhang; Teresa Silva; Timur Yarovinsky; Thomas D Manes; Sina Tavakoli; Lei Nie; George Tellides; Jordan S Pober; Jeffrey R Bender; Mehran M Sadeghi
Journal:  Circ Res       Date:  2010-06-10       Impact factor: 17.367

3.  Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits.

Authors:  Jozef Dulak; Severin P Schwarzacher; Ralf H Zwick; Hannes Alber; Gunda Millonig; Caecilia Weiss; Heike Hügel; Matthias Frick; Alicja Jozkowicz; Otmar Pachinger; Franz Weidinger
Journal:  Vasc Med       Date:  2005-11       Impact factor: 3.239

4.  High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism.

Authors:  Federico Biscetti; Giuseppe Straface; Raimondo De Cristofaro; Stefano Lancellotti; Paola Rizzo; Vincenzo Arena; Egidio Stigliano; Giovanni Pecorini; Kensuke Egashira; Giulia De Angelis; Giovanni Ghirlanda; Andrea Flex
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

Review 5.  The vasa vasorum in diseased and nondiseased arteries.

Authors:  Mary Jo Mulligan-Kehoe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-25       Impact factor: 4.733

Review 6.  Anti-angiogenic activity of rPAI-1(23) and vasa vasorum regression.

Authors:  Mary Jo Mulligan-Kehoe
Journal:  Trends Cardiovasc Med       Date:  2013-01-11       Impact factor: 6.677

Review 7.  Angiogenesis inhibition in the treatment of prostate cancer.

Authors:  Ravi A Madan; William L Dahut
Journal:  Anticancer Agents Med Chem       Date:  2009-12       Impact factor: 2.505

Review 8.  VEGF inhibitors and prostate cancer therapy.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339

9.  ATF-4 and vascular injury: integration of growth factor signaling and the cellular stress response.

Authors:  Michael T Chin
Journal:  Circ Res       Date:  2008-08-15       Impact factor: 17.367

10.  Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention.

Authors:  Mark Slevin; Jerzy Krupinski; Lina Badimon
Journal:  J Angiogenes Res       Date:  2009-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.